SOLID CANCERS
Clinical trials for SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCERS trials appear
Sign up with your email to follow new studies for SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Florida launches AI cancer fight: custom treatments for tough cases
Disease control Recruiting nowThis Florida-based study is testing a new AI-powered approach to find personalized treatments for cancer patients whose disease has returned or stopped responding to standard therapies. It aims to serve 210 patients, with a special focus on reaching children and underserved commu…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for tough cancers: trial tests Triple-Threat drug combo
Disease control Recruiting nowThis study is testing a new drug, TCC1727, combined with other cancer medications for people with advanced solid tumors that have stopped responding to standard treatments. The first part of the study aims to find the safest and most effective dose. The second part will see how w…
Matched conditions: SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tide Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New drug trial targets 'Undruggable' cancer mutation
Disease control Recruiting nowThis study is testing an experimental drug called tunlametinib for people with advanced solid cancers that have stopped responding to other treatments and have a specific genetic change called an NRAS mutation. The main goal is to see if the drug can shrink tumors and control the…
Matched conditions: SOLID CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Feb 17, 2026 14:37 UTC
-
Scientists search for clues in blood and tumors to predict who benefits from cancer immunotherapy
Knowledge-focused Recruiting nowThis study aims to find biological markers in the blood and tumors of patients receiving immunotherapy for advanced solid cancers. Researchers will collect samples from about 770 patients to learn why some people respond well to treatment while others experience side effects or s…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC